MedTrace Logo

Assessing the Performance of Wesper Lab for Obstructive and Central Sleep Apnea

NCT07095413 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-07-31

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effectiveness of the Wesper Lab home sleep apnea test as a tool to aid in the diagnosis of sleep apnea in adult patients (age ≥21 years) who are recommended for an overnight polysomnography (PSG) evaluation. The main questions it aims to answer are:

1. Is Wesper Lab home sleep apnea test as accurate as an in-laboratory sleep study (polysomnography) for the diagnosis of obstructive and central sleep apnea?
2. Is Wesper Lab accurate in a wide range of body types and skin types?

Participants will:

1. Provide informed consent and complete a brief medical history.
2. Undergo an overnight polysomnography sleep study while wearing two Wesper Lab patches and a compatible pulse oximeter.
3. Have a follow-up communication within 5 days post-study to assess any adverse events.

Conditions

  • Sleep Apnea
  • Sleep Apnea, Obstructive
  • Sleep Apnea, Central

Interventions

DIAGNOSTIC_TEST

Wesper Lab Home Sleep Apnea Test

Subjects will wear the Wesper Lab home sleep apnea tests, which includes 2 wireless sensors and a pulse oximeter.

Sponsors & Collaborators

  • Wesper Inc

    lead INDUSTRY

Principal Investigators

  • Chelsie E Rohrscheib, Ph.D · Attend a workshop

  • Ruchir P Patel, M.D. · The Insomnia and Sleep Institute of Arizona

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2025-12-01
Completion
2026-02-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07095413 on ClinicalTrials.gov